Quantum-Si Incorporated reported its financial results for the second quarter of 2026, revealing a total revenue of $344,000, a significant decrease of 41.8% compared to $591,000 in the same period of 2025. For the first half of 2026, revenue totaled $602,000, down 58.0% from $1.4 million in the prior year. The decline in revenue was primarily attributed to reduced sales volumes of instruments and consumables, as customers deferred purchasing decisions in anticipation of the upcoming launch of the Proteus platform, which is now expected to be commercially available in the second quarter of 2027.

The company's gross profit for the second quarter was $172,000, reflecting a 51.0% decrease from $351,000 in the same quarter of 2025. The gross profit margin also fell to 50.0% from 59.4% year-over-year, driven by a change in the mix of products sold. Operating expenses decreased to $25.8 million from $30.5 million in the prior year, primarily due to a reduction in selling, general, and administrative expenses, which fell by 16.1% to $10.0 million. The net loss for the quarter was $23.5 million, an improvement from a loss of $28.8 million in the same quarter of 2025.

Operationally, Quantum-Si's employee headcount was reported at 152 as of June 30, 2026, with a restructuring program announced in August 2026 aimed at streamlining operations and focusing resources on the Proteus development program. This program is expected to result in a workforce reduction of approximately 20%, with one-time cash charges related to severance and other benefits estimated at $2.6 million. The company also entered into a new lease agreement for a facility in San Diego, California, which is expected to replace its existing location.

As of June 30, 2026, Quantum-Si had cash, cash equivalents, and marketable securities totaling $169.9 million, providing sufficient liquidity to fund operations for at least the next twelve months. The company continues to monitor market conditions and may seek additional financing through equity offerings or collaborations to support its ongoing research and development efforts. Looking ahead, Quantum-Si anticipates that the launch of the Proteus platform may impact revenue as customers delay purchases of existing products in favor of the new technology.

About Quantum-Si Inc

Quantum-Si Incorporated develops proteomics research tools, including innovative single-molecule protein sequencing instruments, consumables, and software. Its platforms enable detailed analysis of proteins, variants, and post-translational modifications, serving life sciences research, drug discovery, and diagnostics markets. Focused on broad accessibility, the company offers low-cost, automated solutions to enhance proteomics capabilities across diverse laboratories worldwide. Its technology aims to revolutionize protein analysis with high resolution, automation, and scalability.

This description was generated via AI from an annual report. Updated about 1 year ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.

View the complete official filing on the SEC website.

Read on SEC.gov